Report Detail
Global Gepants Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4565012 |
- 07 November, 2023 |
- Global |
- 76 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Gepants Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Gepants are a class of drugs specifically designed to treat migraine attacks when they occur by targeting the calcitonin gene-related peptide (CGRP) pathway
The Global Info Research report includes an overview of the development of the Gepants Drugs industry chain, the market status of Hospital (Rimegepant, Atogepant), Clinic (Rimegepant, Atogepant), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gepants Drugs.
Regionally, the report analyzes the Gepants Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gepants Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gepants Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gepants Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Rimegepant, Atogepant).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gepants Drugs market.
Regional Analysis: The report involves examining the Gepants Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gepants Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gepants Drugs:
Company Analysis: Report covers individual Gepants Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gepants Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Gepants Drugs. It assesses the current state, advancements, and potential future developments in Gepants Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gepants Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gepants Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Rimegepant
Atogepant
Zavegepant
Ubrogepant
Market segment by Application
Hospital
Clinic
Other
Major players covered
PFIZER INC
ABBVIE INC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gepants Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gepants Drugs, with price, sales, revenue and global market share of Gepants Drugs from 2018 to 2023.
Chapter 3, the Gepants Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gepants Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Gepants Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gepants Drugs.
Chapter 14 and 15, to describe Gepants Drugs sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Gepants Drugs
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Gepants Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Rimegepant
- 1.3.3 Atogepant
- 1.3.4 Zavegepant
- 1.3.5 Ubrogepant
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Gepants Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Global Gepants Drugs Market Size & Forecast
- 1.5.1 Global Gepants Drugs Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Gepants Drugs Sales Quantity (2018-2029)
- 1.5.3 Global Gepants Drugs Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 PFIZER INC
- 2.1.1 PFIZER INC Details
- 2.1.2 PFIZER INC Major Business
- 2.1.3 PFIZER INC Gepants Drugs Product and Services
- 2.1.4 PFIZER INC Gepants Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 PFIZER INC Recent Developments/Updates
- 2.2 ABBVIE INC
- 2.2.1 ABBVIE INC Details
- 2.2.2 ABBVIE INC Major Business
- 2.2.3 ABBVIE INC Gepants Drugs Product and Services
- 2.2.4 ABBVIE INC Gepants Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 ABBVIE INC Recent Developments/Updates
3 Competitive Environment: Gepants Drugs by Manufacturer
- 3.1 Global Gepants Drugs Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Gepants Drugs Revenue by Manufacturer (2018-2023)
- 3.3 Global Gepants Drugs Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Gepants Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Gepants Drugs Manufacturer Market Share in 2022
- 3.4.2 Top 6 Gepants Drugs Manufacturer Market Share in 2022
- 3.5 Gepants Drugs Market: Overall Company Footprint Analysis
- 3.5.1 Gepants Drugs Market: Region Footprint
- 3.5.2 Gepants Drugs Market: Company Product Type Footprint
- 3.5.3 Gepants Drugs Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Gepants Drugs Market Size by Region
- 4.1.1 Global Gepants Drugs Sales Quantity by Region (2018-2029)
- 4.1.2 Global Gepants Drugs Consumption Value by Region (2018-2029)
- 4.1.3 Global Gepants Drugs Average Price by Region (2018-2029)
- 4.2 North America Gepants Drugs Consumption Value (2018-2029)
- 4.3 Europe Gepants Drugs Consumption Value (2018-2029)
- 4.4 Asia-Pacific Gepants Drugs Consumption Value (2018-2029)
- 4.5 South America Gepants Drugs Consumption Value (2018-2029)
- 4.6 Middle East and Africa Gepants Drugs Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Gepants Drugs Sales Quantity by Type (2018-2029)
- 5.2 Global Gepants Drugs Consumption Value by Type (2018-2029)
- 5.3 Global Gepants Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Gepants Drugs Sales Quantity by Application (2018-2029)
- 6.2 Global Gepants Drugs Consumption Value by Application (2018-2029)
- 6.3 Global Gepants Drugs Average Price by Application (2018-2029)
7 North America
- 7.1 North America Gepants Drugs Sales Quantity by Type (2018-2029)
- 7.2 North America Gepants Drugs Sales Quantity by Application (2018-2029)
- 7.3 North America Gepants Drugs Market Size by Country
- 7.3.1 North America Gepants Drugs Sales Quantity by Country (2018-2029)
- 7.3.2 North America Gepants Drugs Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Gepants Drugs Sales Quantity by Type (2018-2029)
- 8.2 Europe Gepants Drugs Sales Quantity by Application (2018-2029)
- 8.3 Europe Gepants Drugs Market Size by Country
- 8.3.1 Europe Gepants Drugs Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Gepants Drugs Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Gepants Drugs Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Gepants Drugs Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Gepants Drugs Market Size by Region
- 9.3.1 Asia-Pacific Gepants Drugs Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Gepants Drugs Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Gepants Drugs Sales Quantity by Type (2018-2029)
- 10.2 South America Gepants Drugs Sales Quantity by Application (2018-2029)
- 10.3 South America Gepants Drugs Market Size by Country
- 10.3.1 South America Gepants Drugs Sales Quantity by Country (2018-2029)
- 10.3.2 South America Gepants Drugs Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Gepants Drugs Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Gepants Drugs Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Gepants Drugs Market Size by Country
- 11.3.1 Middle East & Africa Gepants Drugs Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Gepants Drugs Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Gepants Drugs Market Drivers
- 12.2 Gepants Drugs Market Restraints
- 12.3 Gepants Drugs Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Gepants Drugs and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Gepants Drugs
- 13.3 Gepants Drugs Production Process
- 13.4 Gepants Drugs Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Gepants Drugs Typical Distributors
- 14.3 Gepants Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Gepants Drugs. Industry analysis & Market Report on Gepants Drugs is a syndicated market report, published as Global Gepants Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Gepants Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
